{"id":37,"date":"2020-04-04T16:43:43","date_gmt":"2020-04-04T16:43:43","guid":{"rendered":"http:\/\/sunpharma-testing.flentas.io\/?page_id=37"},"modified":"2026-05-14T13:33:49","modified_gmt":"2026-05-14T08:03:49","slug":"investors","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/he\/investors\/","title":{"rendered":"Investors"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; background_image=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/03\/investor-banner.jpg&#8221; parallax=&#8221;on&#8221; da_disable_devices=&#8221;off|off|off&#8221; saved_tabs=&#8221;all&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_fullwidth_header title=&#8221;Investor Information&#8221; header_fullscreen=&#8221;on&#8221; button_one_url=&#8221;#visionvalues&#8221; button_two_url=&#8221;#codeofconduct&#8221; _builder_version=&#8221;4.16&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;#f7941e&#8221; title_font_size=&#8221;40px&#8221; title_line_height=&#8221;1.2em&#8221; content_font=&#8221;||||||||&#8221; content_text_color=&#8221;#000000&#8243; content_line_height=&#8221;1.8em&#8221; subhead_font=&#8221;||||||||&#8221; subhead_text_color=&#8221;rgba(0,0,0,0.6)&#8221; subhead_line_height=&#8221;1.4em&#8221; background_color=&#8221;rgba(255,255,255,0.7)&#8221; custom_button_one=&#8221;on&#8221; button_one_text_size=&#8221;20px&#8221; button_one_text_color=&#8221;#ffffff&#8221; button_one_bg_color=&#8221;#f7941e&#8221; button_one_border_width=&#8221;0px&#8221; button_one_font=&#8221;|||on|||||&#8221; button_one_use_icon=&#8221;off&#8221; custom_button_two=&#8221;on&#8221; button_two_text_size=&#8221;20px&#8221; button_two_text_color=&#8221;rgba(0,0,0,0.7)&#8221; button_two_bg_color=&#8221;#ffffff&#8221; button_two_border_width=&#8221;0px&#8221; button_two_font=&#8221;|||on|||||&#8221; button_two_use_icon=&#8221;off&#8221; button_two_custom_margin=&#8221;||||false|false&#8221; button_two_custom_margin_tablet=&#8221;&#8221; button_two_custom_margin_phone=&#8221;|||1px|false|false&#8221; button_two_custom_margin_last_edited=&#8221;on|desktop&#8221; button_two_custom_padding=&#8221;||||false|false&#8221; background_layout=&#8221;light&#8221; width=&#8221;50%&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;fade&#8221; animation_duration=&#8221;500ms&#8221; animation_delay=&#8221;300ms&#8221; title_font_tablet=&#8221;&#8221; title_font_phone=&#8221;&#8221; title_font_last_edited=&#8221;on|phone&#8221; content_font_tablet=&#8221;&#8221; content_font_phone=&#8221;&#8221; content_font_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_2_font=&#8221;|700|||||||&#8221; header_2_text_color=&#8221;#f7941e&#8221; header_2_font_size=&#8221;25px&#8221; header_2_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: center\"><strong>Last Five Years&#8217; Financial Results<\/strong><\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/Sales_FY21-FY25.png&#8221; alt=&#8221;Sales&#8221; title_text=&#8221;Sales_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/Net_Profit_FY21-FY25.png&#8221; title_text=&#8221;Net_Profit_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/Earnings_Per_Share_FY21-FY25.png&#8221; title_text=&#8221;Earnings_Per_Share_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/India_Sales_FY21-FY25.png&#8221; title_text=&#8221;India_Sales_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/US_Sales_FY21-FY25.png&#8221; title_text=&#8221;US_Sales_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/Emerging_Markets_Sales_FY21-FY25.png&#8221; title_text=&#8221;Emerging_Markets_Sales_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/Rest_of_World_Sales_FY21-FY25.png&#8221; title_text=&#8221;Rest_of_World_Sales_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/API_Others_Sales_FY21-FY25.png&#8221; title_text=&#8221;API_Others_Sales_FY21-FY25&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; border_color_all=&#8221;#000000&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; width=&#8221;94.4%&#8221; custom_padding=&#8221;||30px||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(0,0,0,0)&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_2_font=&#8221;|700|||||||&#8221; header_2_text_color=&#8221;#f7941e&#8221; header_2_font_size=&#8221;25px&#8221; header_2_line_height=&#8221;1.2em&#8221; header_3_font=&#8221;|600|||||||&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Financial Results<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;5px||5px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2025 &#8211; 26<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/07\/SPIL-Q1FY26-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/07\/Press-Release-Sun-Pharma-Q1FY26-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/07\/FY26-Q1-Earnings-Call-Recording-10034071.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/08\/FY26-Q1-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/07\/Press-Release-Sun-Pharma-Q1FY26-financial-result-on-July-31-2025.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (July- Sept)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/11\/SPIL-Q2FY26-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/11\/Press-Release-Sun-Pharma-Q2FY26-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/11\/FY26-Q2-Earnings-Call-Recording-10036585.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/11\/FY26-Q2-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/10\/Press-Release-earnings-call-of-Q2FY26-financial-result-on-November-05-2025.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/01\/SPIL-Q3FY26-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/01\/Press-Release-Sun-Pharma-Q3FY26-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/01\/FY26-Q3-Earnings-Call-Recording-10039711.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/02\/FY26-Q3-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/01\/Press-Release-Sun-Pharma-Q3FY26-financial-result-on-January-31-2026.pdf\">Earnings Call Intimation<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; hover_enabled=&#8221;0&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/05\/Press-Release-Sun-Pharma-Q4FY26-financial-result-on-May-22-2026.pdf\">Earnings Call Intimation<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;5px||5px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2024 &#8211; 25<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/07\/Press-Release-Sun-Pharma-Q1-FY25-financial-result-on-August-01-2024.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><\/a><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/08\/SPIL-Q1FY25-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/08\/Press-Release-Sun-Pharma-Q1FY25-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/08\/SUN0320240801154212_Q1FY25-Earnings-Call-Recording.mp3\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/08\/FY25-Q1-Earnings-Call-Transcript.pdf\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/07\/Press-Release-Sun-Pharma-Q1-FY25-financial-result-on-August-01-2024.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (July- Sept)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/10\/SPIL-Q2FY25-Financial-Results.pdf\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-Sun-Pharma-Q2FY25-Financial-Result.pdf\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/10\/FY25-Q2-Earnings-Call-Recording-SUN0320241028155842.mp3\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/11\/FY25-Q2-Earnings-Call-Transcript.pdf\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-Sun-Pharma-Q2-FY25-financial-result-on-October-28-2024.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct- Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/SPIL-Q3FY25-Financial-Results.pdf\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/Press-Release-Sun-Pharma-Q3FY25-Financial-Result.pdf\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/FY25-Q3-Earnings-Call-Recording-10029134.mp3\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/02\/FY25-Q3-Earnings-Call-Transcript.pdf\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/Press-Release-Sun-Pharma-Q3-FY25-financial-result-on-January-31-2025.pdf\">Earnings Call Intimation<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/05\/SPIL-Q4FY25-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/05\/Press-Release-Sun-Pharma-Q4FY25-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/05\/FY25-Q4-Earnings-Call-Recording-10032379.mp3\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/05\/FY25-Q4-Earnings-Call-Transcript.pdf\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/05\/Press-Release-Sun-Pharma-Q4FY25-financial-result-on-May-22-2025.pdf\">Earnings Call Intimation<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;5px||5px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2023 &#8211; 24<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/08\/SPIL-Q1-FY24-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Financials Result\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/08\/press-release-financial.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Press Releases\">Press Releases<\/a><\/p>\n<p style=\"font-weight: 400;\"><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/08\/SUN0320230803148043_Q1FY24_Earnings-Call-Audio-Recording.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p style=\"font-weight: 400;\"><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/08\/FY24-Q1-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/07\/Press-Release-Sun-Pharma-Q1-FY24-financial-result-on-August-03-2023.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/FY24-Q1-Shareholding__Pattern.pdf\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sept)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/11\/SPIL-Q2FY24-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/11\/Press-Release-Sun-Pharma-Q2FY24-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/11\/SUN0320231101149478_Q2FY24_Earnings_Call_Recording.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/11\/FY24-Q2-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/10\/Press-Release-Sun-Pharma-Q2-FY24-financial-result-on-November-01-2023..pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/FY24-Q2-Shareholding__Pattern.pdf\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/SPIL-Q3FY24-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/Press-Release-Sun-Pharma-Q3FY24-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/SUN0320240131150889_Q3FY24_Earnings_Call_Recording.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/02\/FY24-Q3-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/Press-Release-Sun-Pharma-Q3-FY24-financial-result-on-January-31-2024.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/05\/SPIL-Q4FY24-Financial-Results.pdf\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Sun-Pharma-Q4FY24-Financial-Result.pdf\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/05\/SUN0320240522153113_Q4FY24-Earnings-Call-Recording.mp3\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/05\/FY24-Q4-Earnings-Call-Transcript.pdf\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Sun-Pharma-Q4-FY24-financial-result-on-May-22-2024.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2022 &#8211; 23<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;background: #fff;||padding: 12px;||box-shadow: 0px 0px 8px 0px #eaeaea;&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/07\/SPIL-Q1FY23-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/07\/Press-Release-Sun-Pharma-Q1FY23-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/07\/Q1-FY22-23-SPIL-Conf-Call.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/08\/FY23-Q1-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/07\/SHP_June-30-2022_Website.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;background: #fff;||padding: 12px;||box-shadow: 0px 0px 8px 0px #eaeaea;&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/11\/SPIL-Q2FY23-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/11\/Press-Release-Sun-Pharma-Q2FY23-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/11\/Q2-FY22-23-SPIL-Earnings-Call-Audio-Recording.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/11\/FY23_Q2_Earnings_Call_Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/10\/SHP_Q2FY23.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;background: #fff;||padding: 12px;||box-shadow: 0px 0px 8px 0px #eaeaea;&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/01\/SPIL-Q3FY23-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/01\/Press-Release-Sun-Pharma-Q3FY23-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/02\/Q3-FY22-23-SPIL-Earnings-Call-Audio-Recording.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/02\/FY23-Q3-Earnings-Call-Transcript-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/01\/Shareholding-pattern-as-of-31-Dec-22.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;background: #fff;||padding: 12px;||box-shadow: 0px 0px 8px 0px #eaeaea;&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan- Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/05\/Q4FY23-Financial-Result-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/05\/Press-Release-Sun-Pharma-Q4FY23-Financial-Result-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/05\/SUN0320230526146870-Q4FY23-Conf.-Call-Audio.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio Recording<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/06\/FY23-Q4-Earnings-Call-Transcript-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/05\/Press-Release-Sun-Pharma-Q4-FY23-financial-result-on-May-26-2023-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Intimation<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/06\/SHP_31.03.2023_final-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2021 &#8211; 22<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/07\/SPIL-Q1FY22-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/07\/Press-Release-Sun-Pharma-Q1FY22-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/07\/Press-Release-Sun-Pharma-Q1FY22-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/03\/SHP_30062021.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/11\/SPIL-Q2FY22-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/11\/Press-Release-Sun-Pharma-Q2FY22-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/11\/FY22-Q2-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/03\/SHP_30.09.2021.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/01\/SPIL-Q3FY22-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/01\/SPIL-Q3FY22-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/02\/FY22-Q3-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/03\/SHP_31122021-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/SPIL-Q4FY22-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/Press-Release-Sun-Pharma-Q4FY22-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/Q4-FY21-22-SPIL-Conf-Call.mp3\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Audio<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/FY22-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call\u00a0 Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/SHP-31032022.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;1rem&#8221; height=&#8221;1rem&#8221; custom_padding=&#8221;||0px||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(0,0,0,0)&#8221; custom_padding=&#8221;||27px|||&#8221; da_disable_devices=&#8221;off|off|off&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(0,0,0,0)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2020 &#8211; 21<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/Q1FY20-21-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Release-Sun-Pharma-Q1-FY21-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/FY21-Q1-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/SHP_30.06.2020_FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q2FY21-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Release-Sun-Pharma-Q2-FY21-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY20-21-Q2-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/SHP_30.09.2020_Final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/02\/SPIL-Q3FY21-Financials-Results-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/02\/Press-Release-Sun-Pharma-Q3FY21-Financial-Result-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/02\/FY21-Q3-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/02\/SHP_31.12.2020_Final-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/05\/SPIL-Q4FY21-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/05\/Press-Release-Sun-Pharma-Q4FY21-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/06\/FY21-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/05\/SHP_31.03.2021_Final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(0,0,0,0)&#8221; custom_padding=&#8221;||33px|||&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2019 &#8211; 20<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Investor-Presentation-INR-Feb-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Release-Sun-Pharma-Q1-FY20-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/FY20-Q1-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/SHP_30.06.2019.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q2-FY20-SPIL-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Release-Sun-Pharma-Q2-FY20-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/FY20-Q2-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/SHP_30.09.2019.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q3FY20FinancialResult.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/PressReleaseSunPharmaQ3FY20FinancialResult.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/FY20-Q3-Earnings-Call-Transcript-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/SHP_31.12.2019.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q4FY20SPIL-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Release-Sun-Pharma-Q4-FY20-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/FY20-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding__Pattern.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; custom_margin=&#8221;||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2650px&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2018 &#8211; 19<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;20px||20px||true|false&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY18-19-Q3-Press-Release-Sun-Pharma-Q3-FY19-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/Q4FY18-19-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY18-19-Q4-Press-Release-Sun-Pharma-Q4-FY19-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY18-19-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY18-19-Q4-Shareholding-Pattern-as-on-31-03-19.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(0,0,0,0)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2017 &#8211; 18<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-1.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-3.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-5.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-5.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-5.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-4.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-6.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-6.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-6.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-2.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-4.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-4.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-4.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2016 &#8211; 17<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/Q1FY16-17-Financial-Results.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY16-17-Q1-Press-Release-Sun-Pharma-Q1-FY17-Financial-Result.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY16-17-Q1-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY16-17-Q1-Shareholding-Pattern-30-06-16.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-7.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-9.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-9.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-9.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-8.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-6.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-8.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY16-17-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-8.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2015 &#8211; 16<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-9.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-11.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-11.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-11.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-11.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-13.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-13.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-13.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-12.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-14.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-14.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-14.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-10.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-12.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-12.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-12.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2014 &#8211; 15<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-14.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Results-Press-Release-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-18.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-16.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-16.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-16.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-20.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-18.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-17.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-17.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-21.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-19.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-15.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-15.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-19.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-17.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2013 &#8211; 14<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-18.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-22.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-20.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-19.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-20.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-24.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-22.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-20.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-21.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-25.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-23.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-18.xlsx\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-19.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-23.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-21.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2012 &#8211; 13<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-1.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-22.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-26.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-24.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-3.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-24.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-28.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-26.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-4.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-25.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-27.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-2.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-23.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-27.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-25.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2011 &#8211; 12<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q1FY2011-12-Financial-Results.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-26.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-30.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY11-12-Q1-SPILShareholding-Pattern-30-06-2011-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-6.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-28.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-33.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY11-12-Q2-Shareholding-Pattern-30-09-11.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-7.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-34.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-31.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-5.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-27.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-32.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2010 &#8211; 11<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q1FY2010-11-Financial-Results.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q1FY2010-11-Results-Press-Release.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q1FY2010-11-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY10-11-Q1-Shareholding-Pattern-30-06-10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q2FY2010-11-Financial-Results.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-31.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-36.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY10-11-Q2-Shareholding-Pattern-30-09-10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-9.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-32.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-37.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY10-11-Q3-Shareholding-Pattern-31-12-10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-8.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-30.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-35.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-32.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(242,159,78,0.06)&#8221; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2009 &#8211; 10<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-10.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-33.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-38.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY09-10-Q1-Shareholding-Pattern-30-06-09-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-12.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-35.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-40.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY09-10-Q2-Shareholding-Pattern-30-09-09pdf.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-13.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-36.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-41.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY09-10-Q1-Shareholding-Pattern-30-06-09.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;||||||||&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-11.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-34.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-39.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-36.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2008 &#8211; 09<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-14.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-37.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY08-09-Q1-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY08-09-Q1-Shareholding-Pattern-30-06-08.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-16.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-39.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-44.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY08-09-Q2-Shareholding-Pattern-30-09-08.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-17.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY08-09-Q3-Financial-Press-Release.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-45.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY08-09-Q3-Shareholding-Pattern-31-12-08.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-15.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-38.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-43.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-40.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2007 &#8211; 08<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/Q1FY07-08-Financial-Results.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-41.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-46.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY07-08-Q1-Shareholding-Pattern-30-06-07.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-20.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-43.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-48.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY07-08-Q2-Shareholding-Pattern-30-09-07-.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-21.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-44.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-49.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-46.pdfhttps:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY07-08-Q3-Shareholding-Pattern-31-12-07.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-19.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-42.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-47.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-44.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2006 &#8211; 07<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-22.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-45.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-50.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY06-07-Q1-Shareholding-Pattern-30-06-06.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-24.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-47.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-52.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY06-07-Q2-Shareholding-Pattern-30-09-06.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-25.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-48.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-53.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY06-07-Q3-Shareholding-Pattern-31-12-06.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-23.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-46.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-51.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-48.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2005 &#8211; 06<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-27.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-50.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-55.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY05-06-Q1-Shareholding-Pattern-30-06-05.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/Q2FY05-06-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<br \/><\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY05-06-Q2-Financial-Press-Release.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><span style=\"font-size: 16px\"><\/span><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-57.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-size: 16px\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY05-06-Q2-Shareholding-Pattern-30-09-05.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Q3FY2005-06-Financial-Results.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-52.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-58.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY05-06-Q3-Shareholding-Pattern-31-12-05.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-28.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-51.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-56.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-53.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2004 &#8211; 05<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-30.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-53.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-59.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY04-05-Q1-Shareholding-Pattern-30-06-04.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-32.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-55.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><span style=\"font-size: 16px\"><\/span><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-61.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-size: 16px\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY04-05-Q2-Shareholding-Pattern-30-09-04.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-33.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-56.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-62.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY04-05-Q3-Shareholding-Pattern-31-12-04.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-31.xls\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-54.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-60.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-57.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2003 &#8211; 04<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-57.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-63.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY03-04-Q1-SPILShareholding-Pattern-30-06-2003.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-5.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-59.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><span style=\"font-size: 16px\"><\/span><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-64.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-size: 16px\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY03-04-Q2-Shareholding-Pattern-30-09-03.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-6.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-60.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY03-04-Q3-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY03-04-Q3-Shareholding-Pattern-31-12-03.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-4.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-58.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY03-04-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-61.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2002 &#8211; 03<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-7.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-61.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-65.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-64.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-9.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-63.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-67.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-size: 16px\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-66.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-64.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-62.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><\/a><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-68.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY02-03-Q3-Shareholding-Pattern-31-12-02.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-8.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-62.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY02-03-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-65.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_enable_color=&#8221;off&#8221; da_disable_devices=&#8221;off|off|off&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2001 &#8211; 02<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-11.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-65.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-68.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-12.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-67.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<br \/> <\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY02-03-Q2-Shareholding-Pattern-30-09-02.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Earnings-Call-Transcript-67.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-size: 16px\"><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-13.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-68.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY02-03-Q3-Shareholding-Pattern-31-12-02.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-8.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><\/a><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/Q4FY01-02-Financial-Results-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-66.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/FY01-02-Q4-Earnings-Call-Transcript.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Earnings Call Transcript<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Shareholding-Pattern-69.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding Pattern<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgb(252 200 155 \/ 20%)&#8221; da_disable_devices=&#8221;off|off|off&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2000 &#8211; 01<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;20px||20px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-14.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-69.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/01\/Q4FY01-02-Financial-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-71.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-72.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Financials-15.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Financials<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Press-Releases-70.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Press Releases<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<style><!-- [et_pb_line_break_holder] -->#post-37 .inves_quar .et_pb_module.et_pb_bg_layout_light {<!-- [et_pb_line_break_holder] -->  background: #fff !important;<!-- [et_pb_line_break_holder] -->  padding: 12px !important;<!-- [et_pb_line_break_holder] -->  box-shadow: 0px 0px 8px 0px rgb(0 0 0 \/ 15%) !important;<!-- [et_pb_line_break_holder] -->} <!-- [et_pb_line_break_holder] --><\/style>\n<p>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Last Five Years&#8217; Financial ResultsFinancial Results2025 &#8211; 26Quarter 1 (Apr-Jun) Financials Press Release Earnings Call Audio Recording Earnings Call Transcript Earnings Call IntimationQuarter 2 (July- Sept) Financials [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-37","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Our Investor Information | Sun Pharmaceutical Industries Limited<\/title>\n<meta name=\"description\" content=\"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dev.sunpharma.com\/he\/investors\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our Investor Information | Sun Pharmaceutical Industries Limited\" \/>\n<meta property=\"og:description\" content=\"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/he\/investors\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-14T08:03:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"13 \u05d3\u05e7\u05d5\u05ea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/\",\"name\":\"Our Investor Information | Sun Pharmaceutical Industries Limited\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\"},\"datePublished\":\"2020-04-04T16:43:43+00:00\",\"dateModified\":\"2026-05-14T08:03:49+00:00\",\"description\":\"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/\",\"name\":\"Sun Pharmaceutical Industries Ltd.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.sunpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our Investor Information | Sun Pharmaceutical Industries Limited","description":"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dev.sunpharma.com\/he\/investors\/","og_locale":"he_IL","og_type":"article","og_title":"Our Investor Information | Sun Pharmaceutical Industries Limited","og_description":"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.","og_url":"https:\/\/dev.sunpharma.com\/he\/investors\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2026-05-14T08:03:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"13 \u05d3\u05e7\u05d5\u05ea"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/investors\/","url":"https:\/\/dev.sunpharma.com\/investors\/","name":"Our Investor Information | Sun Pharmaceutical Industries Limited","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/#website"},"datePublished":"2020-04-04T16:43:43+00:00","dateModified":"2026-05-14T08:03:49+00:00","description":"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/investors\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/investors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"Investors"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/#website","url":"https:\/\/dev.sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/37","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=37"}],"version-history":[{"count":353,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/37\/revisions"}],"predecessor-version":[{"id":19231,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/37\/revisions\/19231"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=37"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}